| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts
|
Gourdeau, Henriette
|
|
2002
|
50 |
6 |
p. 490-496
|
article
|
| 2 |
Clinical pharmacokinetics, pharmacodynamics and metabolism of the novel matrix metalloproteinase inhibitor ABT-518
|
Crul, Mirjam
|
|
2002
|
50 |
6 |
p. 473-478
|
article
|
| 3 |
Cytosolic and microsomal activation of doxifluridine and tegafur to produce 5-fluorouracil in human liver
|
Ozawa, Shogo
|
|
2002
|
50 |
6 |
p. 454-458
|
article
|
| 4 |
Decreased tumor blood flow as measured by positron emission tomography in cancer patients treated with interleukin-1 and carboplatin on a phase I trial
|
Logan, Theodore F.
|
|
2002
|
50 |
6 |
p. 433-444
|
article
|
| 5 |
Development of an optimal pharmacokinetic sampling schedule for rubitecan administered orally in a daily times five schedule
|
Schoemaker, Nadja E.
|
|
2002
|
50 |
6 |
p. 514-517
|
article
|
| 6 |
Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat
|
Liu, Jing
|
|
2002
|
50 |
6 |
p. 445-453
|
article
|
| 7 |
In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines
|
Avramis, Ioannis A.
|
|
2002
|
50 |
6 |
p. 479-489
|
article
|
| 8 |
Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemia
|
Cortes, Jorge
|
|
2002
|
50 |
6 |
p. 497-500
|
article
|
| 9 |
Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol
|
Thomas, James P.
|
|
2002
|
50 |
6 |
p. 465-472
|
article
|
| 10 |
The doxorubicin-cardioprotective drug dexrazoxane undergoes metabolism in the rat to its metal ion-chelating form ADR-925
|
Schroeder, Patricia E.
|
|
2002
|
50 |
6 |
p. 509-513
|
article
|
| 11 |
The raltitrexed-vinorelbine combination: a phase I pharmacokinetic and pharmacodynamic trial in advanced breast cancer
|
Ferrero, Jean-Marc
|
|
2002
|
50 |
6 |
p. 459-464
|
article
|
| 12 |
Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor- or human xenograft-bearing mice
|
Papadopoulou, Maria V.
|
|
2002
|
50 |
6 |
p. 501-508
|
article
|
Journal description